In patients with diabetes and albuminuria, the HRs for MACE, HHF, and CKD progression with triple combination therapy were estimated to be 0.65 (95% CI 0.550.76), 0.45 (95% CI 0.340.58), and 0.42 (95% CI 0.310.56), respectively, compared with those for conventional therapy alone (renin-angiotensin system inhibitors and classical risk factor management)
A case of pseudohyperaldosteronism induced by yokukansan and shakuyakukanzoto that resulted in severe hypokalemia
Patients with darker skin tones who want to address specific concerns like hyperpigmentation, dark spots or uneven tone can benefit from the treatment
Go in fast for bleeding, black stools, fever, severe pain, fainting, or fast weight loss
Recently, Liu et al